Skip to main content

Table 3 Patient characteristics

From: The added diagnostic value of complementary gadoxetic acid-enhanced MRI to 18F-DOPA-PET/CT for liver staging in medullary thyroid carcinoma

Patient data
Number of patients36
Age (years)55 (43–67)
Female14 (39%)
Calcitonin level (pg/mL)1377 (279–2850)
CEA level (pg/mL)19 (5–125)
Liver metastases16 (44%)
Lymph node metastases31 (86%)
Pulmonary metastases11 (31%)
Bone metastases7 (19%)
Soft tissue metastases1 (3%)
Hereditary MTC5 (14%)
  1. Values presented are count (percentage) for categorical and median (interquartile range) for ordinal or continuous variables
  2. CEA carcinoembryonic antigen, MTC medullary thyroid carcinoma